Daniel J. Brown
FDA investigator
Appears on 1 document from 2009, mostly at sites in Michigan. Most often cites written procedures; deviations (21 CFR 211.100).
- 1
- Documents on file
- 16.0
- Observations per 483
- 2009
- First seen
- 2009
- Most recent
What they cite most
From 16 observations- 21 CFR 211.100Written procedures; deviations2
- 21 CFR 211.192Production record review2
- 21 CFR 211.22Responsibilities of quality control unit2
- 21 CFR 211.111Time limitations on production1
- 21 CFR 211.180General requirements1
- 21 CFR 211.184Component, drug product container, closure, and labeling records1
Activity by year
2009: 1
Where
Michigan 1
Often inspects with
Is Daniel J. Brown coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2009-03-16 | 483 Caraco Pharmaceutical Laboratories, Ltd.Mar 16, 2009 · Detroit, Michigan | Detroit, Michigan | 16 |
About this profile
What does Daniel J. Brown inspect?
Daniel J. Brown appears on 1 document on file covering 1 site, mostly in Michigan.
What do they cite most often?
21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.192 and 21 CFR 211.22.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Daniel J. Brown is dated Mar 16, 2009.